Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2–ERG fusions
Zachary R. Chalmers, Michael C. Burns, Ericka M. Ebot, Garrett M. Frampton, Jeffrey S. Ross, Maha Hussain, Sarki A. Abdulkadir
Topics & Concepts
MedicineProstate cancerTMPRSS2ErgProstateOncologyBenign prostatic hyperplasia (BPH)Internal medicineCancerOphthalmologyDiseaseCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)RetinalProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentCancer Genomics and Diagnostics